NGVT
NGVT
NYSE · Chemicals

Ingevity Corp

$75.92
-0.27 (-0.35%)
As of May 9, 1:26 AM ET ·
Financial Highlights (FY 2026)
Revenue
1.13B
Net Income
-161,867,939
Gross Margin
39.5%
Profit Margin
-14.3%
Rev Growth
-11.2%
D/E Ratio
40.69
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 39.5% 39.5% 54.7% 54.7%
Operating Margin -12.2% -11.0% 9.7% 8.4%
Profit Margin -14.3% -13.6% 8.3% 7.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.13B 1.27B 1.58B 1.41B
Gross Profit 447.10M 503.55M 864.01M 770.79M
Operating Income -137,648,479 -139,524,305 152.89M 118.22M
Net Income -161,867,939 -164,073,820 130.65M 101.13M
Gross Margin 39.5% 39.5% 54.7% 54.7%
Operating Margin -12.2% -11.0% 9.7% 8.4%
Profit Margin -14.3% -13.6% 8.3% 7.2%
Rev Growth -11.2% -11.2% +17.8% +22.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.30B 1.30B 220.13M 210.25M
Total Equity 31.95M 31.95M 1.03B 929.02M
D/E Ratio 40.69 40.69 0.21 0.23
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -18,403,653 -19,690,810 192.21M 179.91M
Free Cash Flow 123.30M 118.87M